In this post hoc analysis of a randomized controlled trial, supplementation with macular carotenoids (lutein, zeaxanthin, and meso-zeaxanthin) reduced some markers of inflammation and serum levels of oxidized LDL. However, several limitations reduce our confidence in the result.
This Study Summary was published on October 1, 2024.
